| PHEN/TPM high dose vs placebo | No demonstrated result | | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
|---|
| weight loss equal to or greater than 5 percent | no data | | weight loss equal to or greater than 10 percent | no data | | cardiovascular events | no data |
TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |
| PHEN/TPM low-dose vs placebo | No demonstrated result | | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
|---|
| weight loss equal to or greater than 5 percent | no data | | weight loss equal to or greater than 10 percent | no data | | cardiovascular events | no data |
TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |
| PHEN/TPM mid-dose vs placebo | No demonstrated result | | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
|---|
| weight loss equal to or greater than 5 percent | no data | | weight loss equal to or greater than 10 percent | no data | | cardiovascular events | no data |
TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |
